Scully C. Oral cancer aetiopathogenesis; past,
present and future aspects. Med Oral Patol Oral Cir Bucal. 2011 May 1;16 (3):e306-11.
doi:10.4317/medoral.16.e306
1. Surveillance Epidemiology and End Results (SEER).
SEER Cancer Statistics Review 1975-2004. National Cancer Institute.
http://seer.cancer.gov/statfacts/html/oralcav. (Accessed 03.07.2010).
2. Llewellyn CD, Johnson NW, Warnakulasuriya KA. Risk
factors for squamous cell carcinoma of the oral
cavity in young people--a comprehensive literature review. Oral Oncol. 2001;37:401-18.
doi:10.1016/S1368-8375(00)00135-4
3. Møller H. Changing incidence of cancer of the
tongue, oral cavity, and pharynx in Denmark. J Oral Pathol
Med. 1989;18:224-9.
doi:10.1111/j.1600-0714.1989.tb00767.x
PMid:2788732
4. Macfarlane GJ, Boyle P, Scully C. Rising mortality from cancer of the tongue
in young Scottish males. Lancet. 1987;2:912.
doi:10.1016/S0140-6736(87)91394-8
5. Macfarlane GJ, Boyle P, Evstifeeva TV, Robertson
C, Scully C. Rising trends of oral cancer mortality among males worldwide: the
return of an old public health problem. Cancer Causes Control. 1994;5:259-65.
doi:10.1007/BF01830246
6. Shiboski CH, Schmidt BL, Jordan RC. Tongue and
tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years.
Cancer. 2005;103:1843-9.
doi:10.1002/cncr.20998
PMid:15772957
7. Herrero R, Castellsagué
X, Pawlita M, Lissowska J, Kee F, Balaram P, et al. Human papillomavirus and oral cancer: the International Agency
for Research on Cancer multicenter study. J Natl
Cancer Inst. 2003;95:1772-83.
PMid:14652239
8. D’Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, et al. Case-control study of human papillomavirus and oropharyngeal
cancer. N Engl J Med. 2007;356:1944-56.
doi:10.1056/NEJMoa065497
PMid:17494927
9. Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston-Martin S,
et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer
Res. 1988;48:3282-7.
PMid:3365707
10. International Agency on Research for Cancer. Smokeless Tobacco and Some
Tobacco-specific N-Nitrosamines. Monographs Vol. 89 Lyon: IARC 2007.
11. Karolinska Institute. Health Risks from Swedish
Snuff. Ed. Cnattingius S, Galanti
R, Grafstrom R, Hergens
M-P, Nyren O, Pershagen G, Wickholm S. 2005. p. 1-95.
12. Warnakulasuriya S, Sutherland G, Scully C.
Tobacco, oral cancer, and treatment of dependence. Oral Oncol.
2005;41:244-60.
doi:10.1016/j.oraloncology.2004.08.010
PMid:15743687
13. Lippman SM, Hong WK. Second malignant tumors in
head and neck squamous cell carcinoma: the
overshadowing threat for patients with early-stage disease. Int
J Radiat Oncol Biol Phys. 1989;17:691-4.
doi:10.1016/0360-3016(89)90126-0
14. Ernst E. Harmless herbs? A review of the recent literature. Am J Med.
1998;104:170-8.
doi:10.1016/S0002-9343(97)00397-5
15. Boucher BJ, Mannan N. Metabolic effects of the
consumption of Areca catechu. Addict Biol. 2002;7:103-10.
doi:10.1080/13556210120091464
PMid:11900629
16. Tominaga S. Major avoidable risk factors of cancer.
Cancer Lett. 1999;143 Suppl
1:S19-23.
doi:10.1016/S0304-3835(99)90005-8
17. Petti S, Scully C. Alcohol and oral
health.(2009). In “Food constituents and oral health: current status and future
prospects”Ed: Wilson M. Woodhead
Publishing Ltd.; Cambridge. p. 350-380.
doi:10.1533/9781845696290.2.350
18. Hooper SJ, Wilson MJ, Crean SJ. Exploring the
link between microorganisms and oral cancer: a systematic review of the
literature. Head Neck. 2009;31:1228-39.
doi:10.1002/hed.21140
19. Tezal M, Sullivan MA, Hyland A, Marshall JR, Stoler D, Reid ME, et al. Chronic periodontitis
and the incidence of head and neck squamous cell
carcinoma. Cancer Epidemiol Biomarkers Prev.
2009;18:2406-12.
doi:10.1158/1055-9965.EPI-09-0334
20. Abnet CC, Kamangar F, Islami F, Nasrollahzadeh D,
Brennan P, Aghcheli K, et al. Tooth loss and lack of
regular oral hygiene are associated with higher risk of esophageal squamous cell carcinoma. Cancer Epidemiol
Biomarkers Prev. 2008;17:3062-8.
doi:10.1158/1055-9965.EPI-08-0558
21. Meurman JH, Uittamo J.
Oral micro-organisms in the etiology of cancer. Acta Odontol Scand. 2008;66:321-6.
doi:10.1080/00016350802446527
PMid:18821087
22. Homann N, Tillonen J, Meurman JH, Rintamäki H, Lindqvist C, Rautio M, et al.
Increased salivary acetaldehyde levels in heavy drinkers and smokers: a
microbiological approach to oral cavity cancer. Carcinogenesis. 2000;21:663-8.
doi:10.1093/carcin/21.4.663
PMid:10753201
23. O’Grady JF, Reade PC. Candida albicans as a
promoter of oral mucosal neoplasia. Carcinogenesis.
1992;13:783-6.
doi:10.1093/carcin/13.5.783
PMid:1586990
24. Tillonen J, Homann N, Rautio M, Jousimies-Somer H, Salaspuro M. Role of yeasts in the salivary acetaldehyde
production from ethanol among risk groups for ethanol-associated oral cavity
cancer. Alcohol Clin Exp Res. 1999;23:1409-15.
doi:10.1111/j.1530-0277.1999.tb04364.x
25. Nieminen MT, Uittamo J,
Salaspuro M, Rautemaa R.
Acetaldehyde production from ethanol and glucose by non-Candida albicans yeasts in vitro. Oral Oncol.
2009;45:e245-8.
doi:10.1016/j.oraloncology.2009.08.002
PMid:19793674
26. Miller CS, Johnstone BM. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91:622-35.
doi:10.1067/moe.2001.115392
PMid:11402272
27. Shillitoe EJ. The role of viruses in squamous cell carcinoma of the oropharyngeal
mucosa. Oral Oncol. 2009;45:351-5.
doi:10.1016/j.oraloncology.2008.08.001
PMid:18952492
28. Feller L, Wood NH, Khammissa RA, Lemmer J. Human papillomavirus-mediated
carcinogenesis and HPV-associated oral and oropharyngeal
squamous cell carcinoma. Part 1: human papillomavirus-mediated carcinogenesis. Head Face Med.
2010;6:14.
doi:10.1186/1746-160X-6-14
29. Feller L, Wood NH, Khammissa RA, Lemmer J. Human papillomavirus-mediated
carcinogenesis and HPV-associated oral and oropharyngeal
squamous cell carcinoma. Part 2: Human papillomavirus associated oral and oropharyngeal
squamous cell carcinoma. Head Face Med. 2010;6:15.
doi:10.1186/1746-160X-6-15
30. Popović B, Jekić
B, Novaković I, Luković
L, Konstantinović V, Babić
M, et al. Cancer genes alterations and HPV infection in oral squamous cell carcinoma. Int J
Oral Maxillofac Surg. 2010;39:909-15.
doi:10.1016/j.ijom.2010.05.007
PMid:20579853
31. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal
DI, Nguyen-Tân PF, et al. Human papillomavirus
and survival of patients with oropharyngeal cancer. N
Engl J Med. 2010;363:24-35.
doi:10.1056/NEJMoa0912217
PMid:20530316 PMCid:2943767
32. D’Souza G, Zhang HH, D’Souza
WD, Meyer RR, Gillison ML. Moderate
predictive value of demographic and behavioral characteristics for a diagnosis
of HPV16-positive and HPV16-negative head and neck cancer. Oral Oncol. 2010;46:100-4.
doi:10.1016/j.oraloncology.2009.11.004
PMid:20036610 PMCid:2818855
33. Shi W, Kato H, Perez-Ordonez B, Pintilie M, Huang
S, Hui A, et al. Comparative prognostic value of
HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal
squamous carcinoma. J Clin Oncol. 2009;27:6213-21.
doi:10.1200/JCO.2009.23.1670
PMid:19884544
34. Chung CH, Gillison ML. Human papillomavirus
in head and neck cancer: its role in pathogenesis and clinical implications. Clin Cancer Res. 2009;15:6758-62.
doi:10.1158/1078-0432.CCR-09-0784
PMid:19861444
35. Adelstein DJ, Ridge JA, Gillison
ML, Chaturvedi AK, D’Souza
G, Gravitt PE, et al. Head and neck squamous cell cancer and the human papillomavirus:
summary of a National Cancer Institute State of the Science Meeting, November
9-10, 2008, Washington, D.C. Head Neck. 2009;31:1393-422.
doi:10.1002/hed.21269
36. Gillison ML. HPV and prognosis for patients with oropharynx cancer. Eur J Cancer.
2009;45 Suppl 1:383-5.
doi:10.1016/S0959-8049(09)70058-9
37. Gillison ML, D’Souza G,
Westra W, Sugar E, Xiao W, Begum S, et al. Distinct
risk factor profiles for human papillomavirus type
16-positive and human papillomavirus type 16-negative
head and neck cancers. J Natl Cancer Inst.
2008;100:407-20.
doi:10.1093/jnci/djn025
PMid:18334711
38. Fakhry C, Westra WH, Li
S, Cmelak A, Ridge JA, Pinto H, et al. Improved
survival of patients with human papillomavirus-positive
head and neck squamous cell carcinoma in a
prospective clinical trial. J Natl Cancer Inst.
2008;100:261-9.
doi:10.1093/jnci/djn011
PMid:18270337
39. Eglin RP, Scully C, Lehner T, Ward-Booth P,
McGregor IA. Detection of RNA complementary to herpes simplex virus in human
oral squamous cell carcinoma. Lancet. 1983;2:766-8.
doi:10.1016/S0140-6736(83)92299-7
40. Zheng Y, Xia P, Zheng
HC, Takahashi H, Masuda S, Takano Y. The screening of viral risk factors in
tongue and pharyngolaryngeal squamous
carcinoma. Anticancer
Res. 2010;30:1233-8.
PMid:20530433
41. Bagan JV, Jiménez Y, Murillo J, Poveda R, Díaz JM, Gavaldá C, et
al. Epstein-Barr virus in oral proliferative verrucous leukoplakia and squamous cell carcinoma: A preliminary study. Med Oral Patol Oral Cir Bucal.
2008;13:E110-3.
42. Jalouli J, Ibrahim SO, Mehrotra
R, Jalouli MM, Sapkota D,
Larsson PA, et al. Prevalence of viral (HPV, EBV, HSV) infections in oral submucous fibrosis and oral cancer from India. Acta Otolaryngol.
2010;130:1306-11.
doi:10.3109/00016481003782041
PMid:20441534
43. Laborde RR, Novakova V,
Olsen KD, Kasperbauer JL, Moore EJ, Smith DI.
Expression profiles of viral responsive genes in oral and oropharyngeal
cancers. Eur J Cancer. 2010;46:1153-8.
doi:10.1016/j.ejca.2010.01.026
PMid:20172712
44. Yen CY, Lu MC, Tzeng CC, Huang JY, Chang HW, Chen
RS, et al. Detection of EBV infection and gene expression in oral cancer from
patients in Taiwan by microarray analysis. J Biomed Biotechnol.
2009;2009:904589.
45. Kis A, Fehér E, Gáll T, Tar I, Boda R, Tóth ED, et al. Epstein-Barr virus prevalence in oral squamous cell cancer and in potentially malignant oral
disorders in an eastern Hungarian population. Eur J
Oral Sci. 2009;117:536-40.
doi:10.1111/j.1600-0722.2009.00660.x
PMid:19758249
46. Freedman ND, Park Y, Subar AF, Hollenbeck AR, Leitzmann MF, Schatzkin A, et al.
Fruit and vegetable intake and head and neck cancer risk in a large United
States prospective cohort study. Int J Cancer.
2008;122:2330-6.
doi:10.1002/ijc.23319
PMid:18092323
47. Bosetti C, Gallus S, Trichopoulou
A, Talamini R, Franceschi
S, Negri E, et al. Influence of the Mediterranean
diet on the risk of cancers of the upper aerodigestive
tract. Cancer Epidemiol Biomarkers Prev.
2003;12:1091-4.
PMid:14578148
48. Warnakulasuriya S. Food, nutrition and oral
cancer. In: Food Constituents and Oral Health; Current Status and Future
Prospects. Ed. Wilson M. Woodhead Publishing 2009. p.
273-295.
49. O’Shaughnessy JA, Kelloff GJ, Gordon GB,
Dannenberg AJ, Hong WK, Fabian CJ, et al. Treatment and prevention of
intraepithelial neoplasia: an important target for
accelerated new agent development. Clin Cancer Res.
2002;8:314-46.
50. Nagao T, Ikeda N, Warnakulasuriya S, Fukano H, Yuasa H, Yano M, et al. Serum antioxidant
micronutrients and the risk of oral leukoplakia among
Japanese. Oral Oncol. 2000;36:466-70.
doi:10.1016/S1368-8375(00)00037-3
51. Conway DI, Petticrew M, Marlborough H, Berthiller J, Hashibe M,
Macpherson LM. Socioeconomic inequalities and oral cancer risk: a systematic
review and meta-analysis of case-control studies. Int
J Cancer. 2008;122:2811-9.
doi:10.1002/ijc.23430
PMid:18351646
52. Llewellyn CD, Linklater K, Bell J, Johnson NW, Warnakulasuriya S. An analysis of risk factors for oral
cancer in young people: a case-control study. Oral Oncol.
2004;40:304-13.
doi:10.1016/j.oraloncology.2003.08.015
PMid:14747062
53. Llewellyn CD, Johnson NW, Warnakulasuriya KA.
Risk factors for oral cancer in newly diagnosed patients aged 45 years and
younger: a case-control study in Southern England. J Oral Pathol
Med. 2004;33:525-32.
doi:10.1111/j.1600-0714.2004.00222.x
PMid:15357672
54. Van Zeeburg HJ, Snijders
PJ, Wu T, Gluckman E, Soulier
J, Surralles J, et al. Clinical and molecular
characteristics of squamous cell carcinomas from Fanconi anemia patients. J Natl
Cancer Inst. 2008;100:1649-53.
doi:10.1093/jnci/djn366
PMid:19001603
55. Fischer DJ, Epstein JB, Morton TH Jr, Schwartz
SM. Reliability of histologic diagnosis of clinically
normal intraoral tissue adjacent to clinically suspicious lesions in former
upper aerodigestive tract cancer patients. Oral Oncol. 2005;41:489-96.
doi:10.1016/j.oraloncology.2004.12.007
PMid:15878753
56. Brennan JA, Mao L, Hruban RH, Boyle JO, Eby YJ, Koch WM, et al. Molecular assessment of histopathological staging in squamous-cell
carcinoma of the head and neck. N Engl J Med.
1995;332:429-35.
doi:10.1056/NEJM199502163320704
PMid:7619114
57. Bilde A, von Buchwald C, Dabelsteen
E, Therkildsen MH, Dabelsteen
S. Molecular markers in the surgical margin of oral carcinomas. J Oral Pathol
Med. 2009;38:72-8.
doi:10.1111/j.1600-0714.2008.00715.x
PMid:19192052
58. Cortesina G, Martone T,
Galeazzi E, Olivero M, De Stefani
A, Bussi M, et al. Staging of
head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node
metastases. Int J Cancer. 2000;89:286-92.
doi:10.1002/1097-0215(20000520)89:3<286::AID-IJC12>3.0.CO;2-U
59. Santhi WS, Sebastian P, Varghese BT, Prakash O, Pillai MR. NF-kappaB and COX-2 during oral tumorigenesis
and in assessment of minimal residual disease in surgical margins. Exp Mol Pathol. 2006;81:123-30.
doi:10.1016/j.yexmp.2006.05.001
PMid:16822500
60. Shaw RJ, Hall GL, Woolgar JA, Lowe D, Rogers SN,
Field JK, et al. Quantitative methylation analysis of
resection margins and lymph nodes in oral squamous
cell carcinoma. Br J Oral Maxillofac Surg.
2007;45:617-22.
doi:10.1016/j.bjoms.2007.04.015
PMid:17559992
61. Shaw RJ, Liloglou T, Rogers SN, Brown JS, Vaughan
ED, Lowe D, et al. Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral
cancer: quantitative evaluation using pyrosequencing.
Br J Cancer. 2006;94:561-8.
doi:10.1038/sj.bjc.6602972
PMid:16449996 PMCid:2361183
62. Ball VA, Righi PD, Tejada
E, Radpour S, Pavelic ZP, Gluckman JL. p53 immunostaining
of surgical margins as a predictor of local recurrence in squamous
cell carcinoma of the oral cavity and oropharynx. Ear
Nose Throat J. 1997;76:818-23.
PMid:9397628
63. Tjebbes GW, Leppers vd Straat FG, Tilanus
MG, Hordijk GJ, Slootweg
PJ. p53 tumor suppressor gene as a clonal marker in
head and neck squamous cell carcinoma: p53 mutations
in primary tumor and matched lymph node metastases. Oral Oncol.
1999;35:384-9.
doi:10.1016/S1368-8375(98)00127-4
64. Lee JJ, Hong WK, Hittelman WN, Mao L, Lotan R, Shin DM, et al. Predicting cancer development in
oral leukoplakia: ten years of translational
research. Clin Cancer Res. 2000;6:1702-10.
PMid:10815888
65. Scully C, Sudbø J, Speight PM. Progress in
determining the malignant potential of oral lesions. J Oral Pathol
Med. 2003;32:251-6.
doi:10.1034/j.1600-0714.2003.00108.x
PMid:12694347
66. Marron M, Boffetta P,
Zhang ZF, Zaridze D, Wünsch-Filho
V, Winn DM, et al. Cessation of alcohol drinking, tobacco smoking and the
reversal of head and neck cancer risk. Int J Epidemiol. 2010;39:182-96.
doi:10.1093/ije/dyp291
PMid:19805488 PMCid:2817090
67. Poate TW, Warnakulasuriya
S. Effective management of smoking in an oral dysplasia clinic in London. Oral
Dis. 2006;12:22-6.
doi:10.1111/j.1601-0825.2005.01146.x
PMid:16390464
68. Gillison ML. Human papillomavirus-related
diseases: oropharynx cancers and potential
implications for adolescent HPV vaccination. J Adolesc Health. 2008;43:S52-60.
doi:10.1016/j.jadohealth.2008.07.002
PMid:18809146 PMCid:3037092